Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.9963
-0.0137 (-1.36%)
At close: Jun 12, 2026, 4:00 PM EDT
1.050
+0.054 (5.39%)
After-hours: Jun 12, 2026, 7:59 PM EDT
Revelation Biosciences Employees
Revelation Biosciences had 9 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,389,418
Market Cap
3.89M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 9 | 0 | - | 8 | 1 |
| Dec 31, 2024 | 9 | -1 | -10.00% | 8 | 1 |
| Dec 31, 2023 | 10 | 4 | 66.67% | 9 | 1 |
| Dec 31, 2022 | 6 | - | - | 6 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Virax Biolabs Group | 19 |
| GeoVax Labs | 19 |
| Soligenix | 14 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Galmed Pharmaceuticals | 6 |
| Adial Pharmaceuticals | 5 |
| CDT Equity | 4 |
REVB News
- 2 days ago - Revelation Biosciences Earnings release - Filings
- 2 days ago - Revelation Biosciences Earnings release - Filings
- 13 days ago - Revelation Biosciences adds two new members to AKI Advisory Board - TheFly
- 13 days ago - Revelation Biosciences Expands Acute Kidney Injury Advisory Board - Accesswire
- 4 weeks ago - Revelation Biosciences reports FY25 EPS ($14.35) vs ($1,052.16) last year - TheFly
- 4 weeks ago - Revelation Biosciences, Inc. Releases Corporate Update Letter to Stockholders - Accesswire
- 5 weeks ago - Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026 - Accesswire
- 2 months ago - Revelation Biosciences announces formation of AKI advisory board - TheFly